Rozemarije Holewijn (1987) trained as a neurosurgeon at Amsterdam UMC, where she also completed a PhD in Deep Brain Stimulation for Parkinson's Disease. In 2025, she joined CHDR and is currently serving as the Director of CHDR Twente. In this role, she is responsible for establishing and expanding the CHDR research unit in Twente, Enschede, which will focus on early phase drug development and experimental medicine.